FDA Orders Black Box Warning On 3 Insomnia Drugs After 66 Adverse Events
SILVER SPRING, Md. — The Food and Drug Administration on April 30 announced that it is requiring black box warnings on three insomnia drugs after receiving 66 adverse event reports that...To view the full article, register now.
Already a subscriber? Click here to view full article